Shambhavi S, Singh H, Ramaprasad G, et al. Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis. World J Oncol. 2025;16(4):331-341. doi:10.14740/wjon2613